SCHEMBL25245210

SCHEMBL25245210

C[C@@H](NC(=O)OCc1ccccc1)C1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.53
YAP1 P46937 3/20 0.52
SYK P43405 1/20 0.52
STS P08842 1/20 0.52
BACE1 P56817 1/20 0.51
P2RX7 Q99572 5/20 0.50
MAPT P10636 2/20 0.50
MAPK1 P28482 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
MEN1 O00255 1/20 0.50
ALDH1A1 P00352 1/20 0.50
POLB P06746 1/20 0.50
KMT2A Q03164 1/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HTT P42858 1/20 0.50
NTSR1 P30989 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17591749 1.00 GPR119 (0.59) GPR119L3MBTL1YAP1SYKSTS
SCHEMBL20329576 0.92 GPR119 (0.54) GPR119L3MBTL1YAP1SYKSTS
SCHEMBL17946176 0.92 GPR119 (0.54) GPR119L3MBTL1YAP1SYKSTS
SCHEMBL3661565 0.89 GPR119 (0.57) GPR119L3MBTL1YAP1SYKSTS
SCHEMBL23011527 0.89 KMT2A (0.59) L3MBTL1MEN1ALDH1A1POLBKMT2A
SCHEMBL23576031 0.89 PREP (0.53) GPR119L3MBTL1SYKMAPK1KMT2A
SCHEMBL17591931 0.89 PREP (0.53) GPR119L3MBTL1SYKMAPK1KMT2A
SCHEMBL22552461 0.88 GPR119 (0.56) GPR119L3MBTL1YAP1SYKSTS
SCHEMBL22552460 0.88 GPR119 (0.56) GPR119L3MBTL1YAP1SYKSTS
SCHEMBL21062628 0.88 GPR119 (0.56) GPR119L3MBTL1YAP1SYKSTS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12503452-B2 Antimicrobial compounds and methods CURZA GLOBAL, LLC (US) 2025-12-23 US disclosed
US-20230159491-A1 Antimicrobial Compounds and Methods NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159491-A1 Antimicrobial Compounds and Methods MPO, NISCH, RPN2 GPR119 4663/4885L3MBTL1 1507/4885YAP1 4136/4885
US-12503452-B2 Antimicrobial compounds and methods MPO, NISCH, RPN2 GPR119 4663/4885L3MBTL1 1507/4885YAP1 4136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.